How to improve outcomes of your viral vectors for gene therapy with high-quality data from biophysical profiling methods

Optimizing your vectors for gene therapy is a daunting task. When developing and optimizing AAVs, concerns such as serotype, storage stability, expression method, and genetic fill level must be addressed before a therapeutic vector reaches clinical application. With biophysical characterization tools, it is possible to address these questions and determine the best formulation for your AAV development needs. The proper tool will give you the high-quality data you require, without using lots of precious sample. Watch this video to learn how NanoTemper is addressing the needs of gene therapy researchers.

Previous Video
Overcome bottlenecks in viral vector manufacturing
Overcome bottlenecks in viral vector manufacturing

The success of your gene therapy vectors is dependent on optimal formulation conditions. Finding a buffer t...

Up next
The importance of molecular interactions and stability in Gene Therapy
The importance of molecular interactions and stability in Gene Therapy

New advances in gene therapy have triggered a resurgence of interest in the field. Though gene therapy offe...

[New] Prometheus Panta with SLS

Build effective AAV vectors for gene therapy with
high-quality stability profiling data

Learn more